常见的血液肿瘤主要包括各类白血病、多发性脊髓瘤以及恶性淋巴瘤。急性白血病占常见恶性肿瘤的第八位，淋巴瘤也是在前十位，并且发病率逐年升高，多发性骨髓瘤的整个发病率在血液恶性肿瘤里面占10%。 以下产品可用于多种常见血液肿瘤研究，急性淋巴细胞白血病（Acute Lymphoblastic Leukemia (ALL)是一种起源于淋巴细胞的B系或T系细胞在骨髓内异常增生的恶性肿瘤疾病。异常增生的原始细胞可在骨髓聚集并抑制正常造血功能，同时也可侵及骨髓外的组织，如脑膜、淋巴结、性腺、肝等。急性髓细胞白血病(acute myelocytic leukemia，AML)包括所有非淋巴细胞来源的急性白血病，是多能干细胞或已轻度分化的前体细胞核型发生突变所形成的一类疾病是造血系统的克隆性恶性疾病。淋巴瘤（Lymphoma）是起源于淋巴造血系统的恶性肿瘤，主要表现为无痛性淋巴结肿大，肝脾肿大。 相关产品列表： |
| 急性淋巴细胞白血病相关抗体 Antibody Catalog No. Host Clone Reactivity Tested Application/s CD3 NBP2-25186 Ms OKT3 Hu FLOW CD19 NBP2-25196 Ms CD19 Hu FLOW, IHC IL2RA/CD25 NBP2-27425 Rt PC61 Ms FLOW CD44 NBP1-47386 Ms 8E2F3 Hu, Ms, Ca, Rb, Eq WB, ELISA, FLOW, ICC/IF, IHC, IHC-P Notch-1 NB100-78486 Ms mN1A Hu, Ms WB, FLOW, ICC/IF, IHC, IHC-P, IP |
| 急性髓细胞样白血病相关抗体 Antibody Catalog No. Host Clone Reactivity Tested Application/s c-Kit NB100-77477 Rt 2B8 Hu, Ms FLOW, IHC, IHC-Fr, IP ETV6/Tel NBP1-80695 Rb poly Hu, Rt WB, ICC/IF, IHC, IHC-P Flt3/CD135 NBP1-43352 Rt A2F10 Ms FLOW, Func, IP Nucleophosmin NB110-61646 Rb poly Hu, Ms WB, FLOW, ICC/IF, IHC, IHC-P, IP RUNX1 NB100-2044 Rb poly Hu, Ms WB |
| 淋巴瘤相关抗体 Antibody Catalog No. Host Clone Reactivity Tested Application/s Bcl2 NB100-56098 Rb poly Hu, Bv, Ca, Fe WB, IHC, IHC-P, IP CD5 NBP2-02690 Ms 7A7 Hu WB, FLOW, ICC/IF, IHC, IHC-P CD10 NBP1-47356 Ms 2A1H5E1 Hu WB, ELISA, ICC/IF, IHC, IHC-P CD15 NBP1-28441 Ms 28 Hu FLOW, IHC, IHC-Fr, IP CD30 NBP2-29425 Ms CD30/412 Hu ELISA, FLOW, ICC/IF, IHC-Fr, IHC-P |
| 多发性骨髓瘤相关抗体 Antibody Catalog No. Host Clone Reactivity Tested Application/s beta 2 microglobulin NB500-317 Ms B2M-01 Hu WB, ELISA, FLOW, IHC, IHC-P, IP, RIA CD38 NBP2-25250 Ms 1G7F4 Hu, Ms WB, IHC, IHC-P CD56 + NCAM-1 NBP2-15184 Ms 123C3 Hu, Rt, Ze WB, ELISA, FLOW, ICC/IF, IHC-Fr, IHC-P, IP IL-6 NB600-1131 Rb poly Hu, Ms, Rt WB, ELISA, ICC/IF, IHC, IHC-P, IP Syndecan 1 NBP1-54523 Ms MI15 Hu FLOW, ICC/IF, IHC, IHC-P |
|
| CD3 NBP02-25186 CD10 NBP1-47356 IL-6 NB600-1131 |
